Total Payments
$1,351
2024 Payments
$449.85
Companies
21
Transactions
42
Payment Breakdown by Category
Food & Beverage$1,351 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,351 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $200.31 | 4 | $0 (2024) |
| Incyte Corporation | $197.21 | 5 | $0 (2023) |
| Kite Pharma, Inc. | $133.65 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $124.98 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $120.74 | 5 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $105.30 | 4 | $0 (2023) |
| Celgene Corporation | $100.07 | 4 | $0 (2024) |
| Genentech USA, Inc. | $80.89 | 3 | $0 (2023) |
| Stemline Therapeutics Inc. | $37.83 | 2 | $0 (2024) |
| Genmab U.S., Inc. | $31.54 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.85 | 11 | ABBVIE INC. ($153.41) |
| 2023 | $454.17 | 11 | Incyte Corporation ($159.24) |
| 2022 | $256.71 | 11 | Celgene Corporation ($55.82) |
| 2021 | $190.44 | 9 | Pharmacyclics LLC, An AbbVie Company ($50.07) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $21.10 | General |
| 10/07/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), TECVAYLI, CARVYKTI | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $116.01 | General |
| Category: CELLT | ||||||
| 08/02/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 03/07/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Oncology | ||||||
| 02/06/2024 | Janssen Scientific Affairs, LLC | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Oncology | ||||||
| 01/10/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $18.20 | General |
| 10/06/2023 | Legend Biotech USA Inc. | CARVYKTI (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 08/07/2023 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $7.76 | General |
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.98 | General |
| 06/13/2023 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $26.35 | General |
| 06/02/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: BioOncology | ||||||
| 05/12/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $23.45 | General |
| 05/09/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: BioOncology | ||||||
| 03/03/2023 | Celgene Corporation | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $23.15 | General |
| Category: Oncology | ||||||
| 02/03/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $125.13 | General |
| Category: Hematology/Oncology | ||||||
| 12/15/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $30.93 | General |
| Category: Hematology | ||||||
| 11/16/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Oncology | ||||||
| 09/08/2022 | Janssen Scientific Affairs, LLC | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Oncology | ||||||
About Jesse Martin, PA-C
Jesse Martin, PA-C is a Medical healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1609174093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jesse Martin, PA-C has received a total of $1,351 in payments from pharmaceutical and medical device companies, with $449.85 received in 2024. These payments were reported across 42 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,351).
Ad
Practice Information
- Specialty Medical
- Location Cartersville, GA
- Active Since 03/09/2011
- Last Updated 06/09/2011
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1609174093
Products in Payments
- JAKAFI (Drug) $163.10
- EPKINLY (Drug) $125.00
- Yescarta (Drug) $116.01
- IMBRUVICA (Drug) $105.30
- DARZALEX (Biological) $72.85
- Venclexta (Biological) $56.30
- ONUREG (Drug) $48.04
- ELZONRIS (Drug) $37.83
- Epkinly (Drug) $31.54
- REBLOZYL (Biological) $30.93
- VENCLEXTA (Drug) $28.41
- DARZALEX (Drug) $25.00
- LIVTENCITY (Drug) $24.92
- VENCLEXTA (Biological) $24.59
- AVYCAZ (Drug) $24.21
- PIPELINE (Device) $22.89
- DALVANCE (Drug) $22.69
- REZUROCK (Drug) $22.66
- NUZYRA (Drug) $21.32
- XPOVIO (Drug) $19.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.